Linking HIV screening with COVID-19 testing at an urban emergency department

What The Study Did: Changes in quality of diet from different sources of food among U.S. children and adults from 2003 to 2018 were examined in this survey study. Authors: Junxiu Liu, Ph.D., of the Icahn School of Medicine at Mount Sinai in New York, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2021.5262) Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions ...

What The Study Did: Researchers compared the risk of death between infants with and without prenatal opioid exposure and also the difference in risk if diagnosed with neonatal opioid withdrawal syndrome. Authors: JoAnna K. Leyenaar, M.D., Ph.D., M.P.H., of Children's Hospital at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamapediatrics.2021.6364) Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including ...

What The Study Did: This study used data from a national database to compare clinical outcomes of surgical patients with and without COVID-19. Authors: Max R. Haffner, M.D., of the University of California, Davis, in Sacramento, is the  corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2021.5697) Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. INFORMATION: Media advisory: The full study is linked to this news release. Embed this link ...

What The Study Did: This modeling study estimates COVID-19-related changes in rates of colorectal cancer screenings and associated outcomes and estimates the degree to which expanded fecal immunochemical testing could potentially mitigate these outcomes. Authors: Rachel B. Issaka, M.D., M.A.S., of the Fred Hutchinson Cancer Research Center in Seattle, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2021.6454) Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and ...

Using an innovative protein-based approach, researchers at the Atlanta Veterans Affairs Medical Center and nearby Emory University have found genes and corresponding proteins that could point the way to new depression treatments. Using a proteome-wide association study (PWAS) that integrated genome-wide association study (GWAS) data with human brain proteomic and genetic data, researchers have identified 19 genes that may lead to depression by altering brain protein levels. They also pinpointed 25 such proteins that offer promise as potential targets for new depression treatments. The researchers detail their approach and findings in April 2021 in the journal Nature ...

Both people and tomatoes come in different shapes and sizes. That is because every individual has a unique set of genetic variations--mutations--that affect how genes act and function. Added together, millions of small genetic variations make it hard to predict how a particular mutation will impact any individual. Cold Spring Harbor Laboratory (CSHL) Professor and Howard Hughes Medical Institute Investigator Zach Lippman showed how genetic variations in tomatoes can influence the way a specific mutation affects the plant. He is working toward being able to predict the effects of mutations on different tomato varieties. In this study, Lippman and his team used CRISPR, a highly accurate and targeted gene-editing tool, on two tomato genes that control fruit ...

An international team today reports the findings of an independent assessment of five commercially-available assays for tumour DNA sequencing - a fast, cheap and less invasive method to diagnose and monitor cancer. The researchers revealed that all assays could reliably detect so-called circulating tumour DNA (ctDNA) when it made up 0.5% of the total DNA in blood, a level of sensitivity that allows detection, genetic analysis and monitoring of late-stage and metastatic tumours. Published in the journal Nature Biotechnology, the study is a major milestone for the use of ctDNA assays as cancer diagnostics, outlining best-practice guidelines ...

An amber fossil of a Cretaceous beetle has shed some light on the diet of one of the earliest pollinators of flowering plants. The animal's remains were unearthed by researchers at the University of Bristol and the Nanjing Institute of Geology and Palaeontology of the Chinese Academy of Sciences (NIGPAS) who were able to study its fossil faecal matter, which was composed solely of pollen. Besides being a visitor of angiosperms - flowering plants - researchers now have conclusive evidence that the new fossil named Pelretes vivificus also fed on their pollen. Details of this discovery have been published ...

Researchers from the National Institutes of Health have identified and tested a drug combination that exploits a weakness in small cell lung cancer (SCLC), an aggressive, dangerous cancer. The scientists targeted a vulnerability in how the cancer cells reproduce, increasing already high levels of replication stress ¬¬-- a hallmark of out-of-control cell growth in many cancers that can damage DNA and force cancer cells to constantly work to repair themselves. In a small clinical trial, the drug duo shrank the tumors of SCLC patients. The team reported its findings April 12 in Cancer Cell. While many patients with small cell lung cancer initially respond to chemotherapy, they lack an effective follow-up treatment. These patients usually live a matter of weeks after their ...

A new test that measures the quantity and quality of inactive HIV viruses in the genes of people living with HIV may eventually give researchers a better idea of what drugs work best at curing the disease. Currently no cure exists for HIV and AIDS, but antiretroviral therapy drugs, or ARTs, effectively suppress the virus to undetectable levels. Published today in Cell Reports Medicine, the study discusses how a new test, developed jointly by scientists at the University of Washington School of Medicine and Fred Hutchinson Cancer Research Center, will ...